Cancer News
OncoLink Cancer News - HealthDay


Mechanism of Neuroblastoma Differentiation Identified

-- A. Agrawal, PhD

Friday, August 28, 2009

FRIDAY, Aug. 28 (HealthDay News) -- Fibroblast growth factor-2 (FGF-2) induces the differentiation of neuroblastoma cells by inducing growth arrest, affecting the epithelium to mesenchyme transition and suppressing a key regulator, according to a study in the September issue of Endocrinology.

Shane Higgins, of the Royal Children's Hospital in Parkville, Australia, and colleagues examined how FGF-2 induces differentiation of neuroblastoma cells and overrides their mitogenic response to insulin-like growth factor-I.

The researchers found that FGF-2 induced cell cycle arrest, modulated genes involved in maintenance of the epithelial phenotype and cell-matrix interactions, and upregulated genes known to contribute to neuronal differentiation and neurite extension. Further investigation showed that inhibitor of differentiation 3 was a key regulator of these events and therefore a possible drug target, according to the study.

"In conclusion, we have shown for the first time that FGF-2 induces differentiation of neuroblastoma cells via activation of a complex gene expression program enabling modulation of cell cycle, transcription factors, and suppression of the cancer phenotype," Higgins and colleagues write.

Abstract
Full Text (subscription or payment may be required)

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.


I Wish You Knew

The culture of a patient is important

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More